KarXT is an investigational medication designed to help improve thinking abilities and overall functioning in people with mild to moderate Alzheimer’s disease. It works by targeting specific brain receptors that are involved in cognitive function.

KarX-EC is a complementary medication used in combination with KarXT. This combination therapy aims to enhance the treatment’s effectiveness in addressing cognitive impairment and improving daily functioning in Alzheimer’s disease patients.

Alzheimer’s Disease – A progressive brain disorder that gradually destroys memory, thinking skills, and the ability to carry out simple tasks. The disease begins with mild memory loss and confusion, which slowly becomes more severe over time. In the mild to moderate stages, people experience increasing problems with memory, planning, language, and spatial awareness. During these stages, individuals may have difficulty remembering recent events, following conversations, managing finances, or navigating familiar places. The disease causes changes in behavior and personality, making daily activities more challenging. The condition involves the abnormal buildup of specific proteins in the brain, leading to the death of brain cells and the disruption of important neural connections.